Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.
about
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyPost-translational modifications as key regulators of TNF-induced necroptosisMolecular crosstalk between apoptosis, necroptosis, and survival signalingAn outline of necrosome triggersThe interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathwaysNecroptosis in acute kidney injury: a shedding lightPeroxiredoxins and the Regulation of Cell DeathNecroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout MiceInterleukin-1 Family Cytokines in Liver DiseasesApoptosis, Necrosis, and Necroptosis in the Gut and Intestinal HomeostasisDeath in the fast lane: what's next for necroptosis?DED or alive: assembly and regulation of the death effector domain complexesThe two faces of receptor interacting protein kinase-1Execution of RIPK3-regulated necrosisProgrammed necrosis in the cross talk of cell death and inflammationThe necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance.Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosisThe Janus Face of Death Receptor Signaling during Tumor ImmunoeditingMolecular Pathogenesis of NASHQuestions and controversies: the role of necroptosis in liver diseaseNon-Canonical Cell Death Induced by p53Linear ubiquitination in immunityNecroptosis: The Trojan horse in cell autonomous antiviral host defenseHerpes Simplex Virus 1 (HSV-1) and HSV-2 Mediate Species-Specific Modulations of Programmed Necrosis through the Viral Ribonucleotide Reductase Large Subunit R1Regulation of tumour necrosis factor signalling: live or let dieInflammasome-activated gasdermin D causes pyroptosis by forming membrane poresIdentification of a Transcription Factor That Regulates Host Cell Exit and Virulence of Mycobacterium tuberculosisMitochondrial Protein PGAM5 Regulates Mitophagic Protection against Cell NecroptosisHsp90 modulates the stability of MLKL and is required for TNF-induced necroptosisA Role for Tubular Necroptosis in Cisplatin-Induced AKIPpm1b negatively regulates necroptosis through dephosphorylating Rip3Noncanocial cell death program independent of caspase activation cascade and necroptotic modules is elicited by loss of TGFβ-activated kinase 1.GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell deathA cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLLaser-mediated rupture of chlamydial inclusions triggers pathogen egress and host cell necrosis.The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis.Emerging roles for lipids in non-apoptotic cell deathAnalysis of necroptotic proteins in failing human hearts.
P2860
Q26739959-9A2DB149-7A18-4441-A93C-C9F3268002B5Q26744244-7AD3D5EF-9D75-4C4B-9F77-CA59654E17CDQ26745680-105DD13C-59D7-4D76-8559-377668E5A146Q26751108-AE2B6634-2DC2-449A-BF54-C0DD785765E2Q26751441-9549A6BD-FC7E-46A6-BC3E-1434842A19BEQ26764791-21B199CB-9966-463F-B4DB-E309AB39E77DQ26774785-61C34707-3BDE-4370-88FD-6B9A0817786FQ26778547-4DCDE362-0DDC-4778-9526-73871D788B84Q26778553-938BD3CE-3F19-4CA3-B037-D02116AE2BE8Q26781665-79CA74D2-6EBC-4D44-BBF0-B4382338952AQ26782124-03A6BF89-65E1-4044-A85B-2DD05C04CBFAQ26796544-E97EADC1-51AD-4A57-8BF8-781827CA234CQ26853682-86F01547-7964-4C92-93B5-ED55693EF911Q27022081-3CF462AA-AB23-44C4-BB5B-8563B2978358Q27026709-F008FCAB-1B48-4E5B-B321-3498E2378338Q27313354-B9A52D68-103F-4FC4-B8F2-E2DAB4A35EFEQ27335987-A413B646-0FED-4E89-88F7-B696E2E2642FQ28070036-35C06F69-6636-46AF-9960-554CEFAB79F9Q28071265-C139C7CE-4B4A-4A0D-9236-2EF9D7552E2BQ28072789-678E6352-E1C9-4465-B44F-9A0A3FEF9CEDQ28080158-3EC87BFA-2678-4A9D-B55A-F5FA5348AA23Q28082899-1A15FB51-1250-4F09-8800-4786441E6DDCQ28087723-534C6802-DD12-47EC-B93A-19BCE1AE0380Q28115766-84AD9E4A-8535-404E-8693-D259CA928ECAQ28262381-0EC12588-573A-411C-B949-7E2125AB8801Q28511994-50FE7097-CD90-40E0-8CE7-53D88FB0A00CQ28552188-44B48A6E-B68A-4FD9-A1E8-3A1374E29909Q28552780-8C2AE50F-04BD-4C98-8591-34D48A7DE93EQ28603628-2D64C992-651E-49B2-AA03-B9A627061D8AQ28608321-753D5B01-7DFB-442A-AF49-A0795F2DBFD0Q28645752-93721825-A1F8-4923-9BF5-F7B6A7A7D86EQ30352395-DDB33717-82C7-4A7D-9FE7-B5A551E6C3C5Q30370004-E7F73540-AC2E-4127-A67D-C6EFE3B07B22Q30396736-09925EBA-D299-4C06-953F-4A3915216BB0Q30408769-699A6EAD-1A6A-4B88-A316-553F0D60983EQ30623992-8968E94E-18D7-4298-BAF4-475DB8089D15Q30842037-739F5C8F-5DE5-4AF8-BF28-F1E4064CDC2FQ33434632-E2399979-BBEA-433C-A489-707DD4411A7FQ33586741-C528889D-9120-4FA4-AB70-58236882D569Q33617839-69C12933-5034-49C7-B0A3-406EC3D39871
P2860
Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@ast
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@en
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@nl
type
label
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@ast
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@en
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@nl
prefLabel
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@ast
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@en
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@nl
P2093
P1433
P1476
Mixed lineage kinase domain-li ...... upon phosphorylation by RIP3.
@en
P2093
Fu-Sheng Wang
Huayi Wang
Li-Feng Wang
Liming Sun
Xiaodong Wang
P304
P356
10.1016/J.MOLCEL.2014.03.003
P50
P577
2014-04-03T00:00:00Z